Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin

Movement Disorders

Volumn 16, Issue 5, 2001, Pages 967-968

  Saverino, A ^a   Solaro, C ^a   Capello, E ^a   Trompetto, C ^a   Abbruzzese, G ^a   Schenone, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; IMMUNOGLOBULIN M;

AGED; ARTICLE; CASE REPORT; CHRONIC DISEASE; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; PARAPROTEINEMIA; PHYSICAL DISABILITY; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT; TREATMENT OUTCOME; TREMOR;

ACETIC ACIDS; AGED; AMINES; ANTIPARKINSON AGENTS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HAND; HUMANS; IMMUNOGLOBULIN M; PARAPROTEINEMIAS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TREMOR;

EID: 0035470404     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1172     Document Type: Article

References (10)

1. Evidente VG, Adler CH, Caviness JN, et al. Effective treatment of orthostatic tremor with gabapentin. Mov Disord 1998;13:829-831.
2. Onofri M, Thomas A, Paci C, D'Andreamatto G. Gabapentin in orthostatic tremor: results of a double-blind crossover with placebo in four patients. Neurology 1998;51:880-882.
3. Pahwa R, Lyons K., Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 1998;13:465-467.
4. Gironell A, Kulisevsky J, Barbanoj M, et al. A randomized placebo controlled comparative trial of gabapentin and propanolol in essential tremor. Arch Neurol 1999; 56:475-480.
5. Ondo W, Hunter C, Dat Vuong K, et al. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 2000;15:678-682.
6. Smith IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaema. Brain 1994;117: 949-957.
7. Bain PG, TC Britton, Jerkins IH, et al. Tremor associated with benign paraproteinaemic neuropathy. Brain 1996;119:789-799.
8. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1993. p 271-279.
9. Taylor CP, Gee NS, Ti-Zhi Su, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29: 233-249.
10. White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 1999; 40(Suppl5):S2-10.